Difference between revisions of "Part:BBa K4165091"

 
Line 3: Line 3:
 
<partinfo>BBa_K4165091 short</partinfo>
 
<partinfo>BBa_K4165091 short</partinfo>
  
−
A serine protease inhibitor is used to inhibit the action of HTRA1
+
This basic part encodes Human serine protease inhibitor secretory leukocyte peptidase inhibitor which is predicted to be able to inhibit HtrA1 (BBa_K4165004).
  
  
  
−
<!-- Add more about the biology of this part here
 
 
===Usage and Biology===
 
===Usage and Biology===
 +
This type of inhibitor is considered to be an acid stable inhibitor with very high affinity for trypsins, chymotrypsine, elastases, and cathepsin G [1]-[6]. This type of inhibitor is very effective and has high affinity for trypsin-like proteases (serine proteases), and in our case it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1[7]-[9].
  
 
<!-- -->
 
<!-- -->
Line 15: Line 15:
  
  
−
<!-- Uncomment this to enable Functional Parameter display
 
 
===Functional Parameters===
 
===Functional Parameters===
 +
GC Content%
 +
67.2%
 +
Isoelectric point (PI)
 +
8.494
 +
Charge at pH 7
 +
10.831
 +
Molecular Weight (Protein)
 +
14.326
 +
 +
===PDB structure===
 +
X-ray and denovo modelling - AlphaFold2
 +
 +
X-ray:
 +
https://www.rcsb.org/structure/2Z7F
 +
Molprobity =
 +
Q_Mean =
 +
Ramachandran Favoured =
 +
Ramachandran Outliers =
 +
Clash Score =
 +
C-beta Deviation =
 +
Rotamers outliers =
 +
Total Score =
 +
 +
AlphaFold:
 +
https://alphafold.ebi.ac.uk/entry/P03973
 +
Molprobity =
 +
Q_Mean =
 +
Ramachandran Favoured =
 +
Ramachandran Outliers =
 +
Clash Score =
 +
C-beta Deviation =
 +
Rotamers outliers =
 +
Total Score =
 +
 +
 +
 +
 +
===References===
 +
1- HEINZEL, R., APPELHANS, H., GASSEN, G., SEEMÜLLER, U., MACHLEIDT, W., FRITZ, H., & STEFFENS, G. (1986). Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. European journal of biochemistry, 160(1), 61-67.
 +
2- Thompson, R. C., & Ohlsson, K. (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proceedings of the National Academy of Sciences, 83(18), 6692-6696.
 +
3- Thompson, R. C., & Ohlsson, K. (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proceedings of the National Academy of Sciences, 83(18), 6692-6696.
 +
4- Eisenberg, S. P., Hale, K. K., Heimdal, P., & Thompson, R. C. (1990). Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. Journal of Biological Chemistry, 265(14), 7976-7981.
 +
5- Mulligan, M. S., Lentsch, A. B., Huber-Lang, M., Guo, R. F., Sarma, V., Wright, C. D., ... & Ward, P. A. (2000). Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor. The American journal of pathology, 156(3), 1033-1039.
 +
6- Fukushima, K., Kamimura, T., & Takimoto-Kamimura, M. (2013). Structure basis 1/2SLPI and porcine pancreas trypsin interaction. Journal of synchrotron radiation, 20(6), 943-947.
 +
7- Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389.
 +
8- Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050.
 +
9- Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.
 +
 +
 
<partinfo>BBa_K4165091 parameters</partinfo>
 
<partinfo>BBa_K4165091 parameters</partinfo>
 
<!-- -->
 
<!-- -->

Revision as of 18:55, 5 October 2022


SLPI (Secretory leukocyte peptidase inhibitor).

This basic part encodes Human serine protease inhibitor secretory leukocyte peptidase inhibitor which is predicted to be able to inhibit HtrA1 (BBa_K4165004).


Usage and Biology

This type of inhibitor is considered to be an acid stable inhibitor with very high affinity for trypsins, chymotrypsine, elastases, and cathepsin G [1]-[6]. This type of inhibitor is very effective and has high affinity for trypsin-like proteases (serine proteases), and in our case it would act as an inhibitor for the trypsin-like catalytic domain of serine protease HtrA1[7]-[9].

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 219
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Functional Parameters

GC Content% 67.2% Isoelectric point (PI) 8.494 Charge at pH 7 10.831 Molecular Weight (Protein) 14.326

PDB structure

X-ray and denovo modelling - AlphaFold2

X-ray: https://www.rcsb.org/structure/2Z7F Molprobity = Q_Mean = Ramachandran Favoured = Ramachandran Outliers = Clash Score = C-beta Deviation = Rotamers outliers = Total Score =

AlphaFold: https://alphafold.ebi.ac.uk/entry/P03973 Molprobity = Q_Mean = Ramachandran Favoured = Ramachandran Outliers = Clash Score = C-beta Deviation = Rotamers outliers = Total Score =



References

1- HEINZEL, R., APPELHANS, H., GASSEN, G., SEEMÜLLER, U., MACHLEIDT, W., FRITZ, H., & STEFFENS, G. (1986). Molecular cloning and expression of cDNA for human antileukoprotease from cervix uterus. European journal of biochemistry, 160(1), 61-67. 2- Thompson, R. C., & Ohlsson, K. (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proceedings of the National Academy of Sciences, 83(18), 6692-6696. 3- Thompson, R. C., & Ohlsson, K. (1986). Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proceedings of the National Academy of Sciences, 83(18), 6692-6696. 4- Eisenberg, S. P., Hale, K. K., Heimdal, P., & Thompson, R. C. (1990). Location of the protease-inhibitory region of secretory leukocyte protease inhibitor. Journal of Biological Chemistry, 265(14), 7976-7981. 5- Mulligan, M. S., Lentsch, A. B., Huber-Lang, M., Guo, R. F., Sarma, V., Wright, C. D., ... & Ward, P. A. (2000). Anti-inflammatory effects of mutant forms of secretory leukocyte protease inhibitor. The American journal of pathology, 156(3), 1033-1039. 6- Fukushima, K., Kamimura, T., & Takimoto-Kamimura, M. (2013). Structure basis 1/2SLPI and porcine pancreas trypsin interaction. Journal of synchrotron radiation, 20(6), 943-947. 7- Clauss, A., Lilja, H., & Lundwall, Å. (2005). The evolution of a genetic locus encoding small serine proteinase inhibitors. Biochemical and biophysical research communications, 333(2), 383-389. 8- Eigenbrot, C., Ultsch, M., Lipari, M. T., Moran, P., Lin, S. J., Ganesan, R., ... & Kirchhofer, D. (2012). Structural and functional analysis of HtrA1 and its subdomains. Structure, 20(6), 1040-1050. 9- Grau, S., Baldi, A., Bussani, R., Tian, X., Stefanescu, R., Przybylski, M., ... & Ehrmann, M. (2005). Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proceedings of the National Academy of Sciences, 102(17), 6021-6026.